Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,061 | 134 | 96.8% |
| Education | $68.40 | 1 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,041 | 65 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $169.00 | 16 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $155.15 | 6 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $139.57 | 9 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $126.11 | 8 | $0 (2022) |
| Lundbeck LLC | $116.92 | 7 | $0 (2022) |
| ITI, Inc. | $81.64 | 5 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $57.55 | 4 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $57.22 | 3 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $44.04 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $269.75 | 18 | ABBVIE INC. ($269.75) |
| 2023 | $296.55 | 15 | ABBVIE INC. ($296.55) |
| 2022 | $1,116 | 79 | ABBVIE INC. ($253.45) |
| 2021 | $447.68 | 23 | AbbVie Inc. ($221.50) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.60 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.37 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.53 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.57 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.13 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $42.21 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.35 | General |
| Category: NEUROSCIENCE | ||||||
| 03/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 27 | 87 | $21,315 | $6,263 |
| 2022 | 1 | 22 | 60 | $14,700 | $4,398 |
| 2021 | 1 | 18 | 18 | $6,750 | $2,375 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 87 | $21,315 | $6,263 | 29.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 60 | $14,700 | $4,398 | 29.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 18 | 18 | $6,750 | $2,375 | 35.2% |
About Casey Mattingly
Casey Mattingly is a Emergency healthcare provider based in Paris, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2020. The National Provider Identifier (NPI) number assigned to this provider is 1114537537.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Casey Mattingly has received a total of $2,130 in payments from pharmaceutical and medical device companies, with $269.75 received in 2024. These payments were reported across 135 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,061).
As a Medicare-enrolled provider, Mattingly has provided services to 67 Medicare beneficiaries, totaling 165 services with total Medicare billing of $13,037. Data is available for 3 years (2021–2023), covering 3 distinct procedure/service records.
Practice Information
- Specialty Emergency
- Other Specialties Psychiatric/Mental Health
- Location Paris, KY
- Active Since 08/01/2020
- Last Updated 12/08/2020
- Taxonomy Code 163WE0003X
- Entity Type Individual
- NPI Number 1114537537
Products in Payments
- VRAYLAR (Drug) $1,041
- QELBREE (Drug) $169.00
- REXULTI (Drug) $142.31
- LATUDA (Drug) $139.57
- TRINTELLIX (Drug) $91.70
- INVEGA SUSTENNA (Drug) $87.72
- CAPLYTA (Drug) $81.64
- SPRAVATO (Drug) $67.43
- INGREZZA (Drug) $57.55
- AUSTEDO (Drug) $44.04
- PERSERIS (Drug) $35.48
- VYVANSE (Drug) $34.41
- Auvelity (Drug) $30.86
- JORNAY PM (Drug) $28.53
- ABILIFY MAINTENA (Drug) $18.55
- LYBALVI (Drug) $17.86
- AZSTARYS (Drug) $16.05
- BRINTELLIX (Drug) $13.28
- APLENZIN (Drug) $12.35
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.